TRIM21 mediates the degradation of branched-chain amino acid transaminase 2 (BCAT2) to inhibit the formation and progression of pancreatic ductal adenocarcinoma [56]. The gene discussed is BCAT2; the disease is pancreatic ductal adenocarcinoma.